New York, USA - August 26, 2024 - "We are excited to join the 15th Annual World Bispecific Summit as an exhibition partner, scheduled to take place from September 3-5, 2024, in Cambridge," shared one of Creative Biolabs' representatives.
Bispecific antibody technology has evolved rapidly in recent years, establishing itself as a groundbreaking advancement in cancer immunotherapy. With the ability to simultaneously recognize and bind two different antigens, bispecific antibodies offer a unique mechanism that enhances the precision and efficacy of treatments.
This year's summit will bring together over 150 industry leaders, scientists, and clinical experts from around the globe to discuss the latest advancements in bispecific antibody development. Key topics include:
* Exploration of Novel Targets: Delve into the emerging targets in bispecific antibody research and their impact on therapeutic outcomes.
* Next-Generation Antibody Formats: Discover innovative antibody designs and development strategies that are setting new standards in therapeutic efficacy and safety.
* Applications of Artificial Intelligence: Explore how AI is transforming bispecific antibody development, from data analysis to drug screening and optimization.
"As a returning exhibitor for the third consecutive year, we are eager to continue showcasing our innovative solutions in bispecific antibody development," the representative added.
Creative Biolabs specializes in the design and development of bispecific antibodies (BsAbs) and offers a comprehensive one-stop platform that includes high-throughput screening, optimization strategies, and case studies of successful projects. Key services include:
* Bispecific Antibody Design
* Bispecific Antibody Purification
* Bispecific Antibody Engineering
* Bispecific Antibody Manufacturing
* Bispecific Antibody Analysis
"Our team of experts will be on-site throughout the event to answer questions about bispecific antibody development. We will provide personalized consultations to address the practical challenges faced during drug development."
Creative Biolabs' bispecific antibody development platform not only offers tailored solutions but also provides a wide range of bispecific antibody products, categorized into formats such as Minibody, Diabody, Bibody, CrossMab, Appended IgGs, and BsIgG.
"In addition to our standardized products, we consistently customize solutions based on our clients' specific needs, with considerations for target selection, structural design, and process optimization," added another representative.
To support diverse research and therapeutic applications, Creative Biolabs offers an extensive selection of bispecific antibody targets, including popular options like Ad fiber knob, BCMA, HER2, EGFR, and PD1. Additionally, the platform can combine multiple targets, such as CD123 & CD3, CD16 & EGFR, and CD3 & HER2, providing a solid foundation for the development of highly effective bispecific antibody drugs.
For more information about bispecific antibody-related services and products, please visit https://www.creative-biolabs.com/bsab.
About Creative Biolabs
The 15th Annual World Bispecific Summit serves as a premier platform for top experts from around the world. Creative Biolabs' exhibition team is poised to seize this opportunity to engage directly with industry leaders, researchers, and partners, sharing its latest research findings and technological advancements in the field of bispecific antibodies. Attendees are invited to visit Booth 12, and those interested in scheduling a meeting can do so at https://events.creative-biolabs.com/15th-annual-world-multispecific-summit.
Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-830-6441
Country: United States
Website: https://www.creative-biolabs.com/bsab
